During this year’s TEDD Annual Meeting, we will explore the clinical applications of advanced cell culture models and highlight their potential in revolutionizing biomedical research and patient care. We will delve into their use in disease modelling, drug screening, personalized medicine, regenerative medicine, and other emerging areas. By examining the current state of the field and discussing recent advancements, we aim to shed light on the transformative potential of these models in clinical practice and pave the way for future developments in this exciting field.
Prof Javad Nazarian University Childrens‘ Hospital Zurich Oncology Department, Switzerland Title: From biopsy to cure: a challenge for precision oncology
Prof Benjamin Gantenbein University of Bern, Medical Faculty, Department for BioMedical Research, Switzerland Title: What regeneration in orthopaedics might bring to an increasingly elderly society
Bianca Fischli(Team of Prof Michael Raghunath) TEDD Competence Centre, Zurich University of Applied Sciences (ZHAW), Switzerland Title: Vascular pattern making using sound induced morphogenesis – experience with the first commercial CymatiX instrument
Dr. Priyanka Dutta-Passecker Healiva SA, Switzerland Title: Unleashing the Potential of Healiva Cell Therapy Models in Advancing Clinical Applications
Dr. Arno Amann Department of Haematology and Oncology, Medical University of Innsbruck, Austria Title: Role of Functional Drug Testing in Precision Oncology
Dr Markus Mühlemann Kugelmeiers, Switzerland Title: The role of standardized spheroids in pancreatic islet transplantation
Dr Deana Mohr MUVON Therapeutics, Switzerland Title: MUVON from bench to bedside
Dr Jakob Pyszkowski Optics11 Life, Amsterdam, Netherlands Title: Stimulation through innovation: A new way to monitor engineered muscle tissues for personalized clinical advances